ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,944	3,913	638.53	3,015	1,179	1,195
Short-Term Investments	630	630	630	630	4,547	120
Trading Asset Securities	-	6,926	410.72	5,769	2,901	1,465
Cash & Short-Term Investments	5,574	11,470	1,679	9,414	8,628	2,781
Cash Growth	42.84%	583.01%	-82.16%	9.11%	210.28%	-2.17%
Accounts Receivable	1,335	1,961	2,930	1,596	1,873	3,497
Other Receivables	191	109.3	108.46	8.07	47.67	3.28
Receivables	3,942	5,989	3,039	1,604	2,321	3,500
Inventory	2,072	2,293	2,375	2,265	2,952	2,106
Prepaid Expenses	79.89	1,031	152.11	16.83	59.27	81.21
Other Current Assets	553.84	70.84	1,144	117.63	163.87	204.67
Total Current Assets	12,222	20,854	8,390	13,417	14,123	8,672
Property, Plant & Equipment	10,485	10,182	11,061	10,312	10,319	10,287
Long-Term Investments	4,086	1,785	1,923	1,585	6,491	1,878
Goodwill	-	-	704.45	1,126	-	-
Other Intangible Assets	29.91	31.69	898.15	1,029	2.4	5.11
Long-Term Accounts Receivable	-0	0	-	-	-	0
Other Long-Term Assets	15,741	15,555	98.42	623.51	83	117.09
Total Assets	42,564	48,407	23,074	28,093	31,018	20,959

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1,577	1,701	1,669	250.65	386.05	1,116
Accrued Expenses	142.76	417.87	336.03	212.78	250.12	341.01
Short-Term Debt	9,466	12,904	6,985	9,142	9,543	9,147
Current Portion of Long-Term Debt	806.64	831.64	653.96	399.08	166.56	773.78
Current Portion of Leases	217.16	37.98	60.72	89.38	21.09	19.92
Other Current Liabilities	12,785	13,749	3,797	1,174	1,426	1,229
Total Current Liabilities	24,994	29,641	13,501	11,268	11,793	12,626
Long-Term Debt	2,728	3,027	3,859	3,513	3,012	3,179
Long-Term Leases	180.77	0.77	413.32	466.24	28.1	49.18
Pension & Post-Retirement Benefits	57.48	57.35	47	71.92	-	-
Long-Term Deferred Tax Liabilities	303.68	303.68	483.29	205.32	-	-
Other Long-Term Liabilities	-	0	0	0	-	-
Total Liabilities	28,264	33,031	18,304	15,525	14,833	15,854

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	9,840	8,180	4,570	4,570	4,570	3,847
Additional Paid-In Capital	39,425	35,617	25,557	27,257	27,257	18,293
Retained Earnings	-33,066	-27,672	-24,381	-16,431	-13,574	-16,270
Comprehensive Income & Other	-836.92	-802.69	-909.44	-2,004	-2,068	-763.03
Total Common Equity	15,362	15,323	4,837	13,393	16,185	5,106
Minority Interest	-1,791	-1,783	-1,862	-2,545	-	-
Shareholders' Equity	14,300	15,377	4,771	12,569	16,185	5,106
Total Liabilities & Equity	42,564	48,407	23,074	28,093	31,018	20,959

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	13,399	16,802	11,972	13,610	12,771	13,168
Net Cash (Debt)	-7,825	-5,332	-10,292	-4,196	-4,143	-10,388
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-543.85	-443.97	-1126.04	-459.08	-410.96	-1351.57
Filing Date Shares Outstanding	19.68	16.36	9.14	9.14	9.14	7.69
Total Common Shares Outstanding	19.68	16.36	9.14	9.14	9.14	7.69
Working Capital	-12,772	-8,788	-5,111	2,149	2,330	-3,954
Book Value Per Share	780.59	936.60	529.16	1465.20	1770.73	663.67
Tangible Book Value	15,332	15,291	3,234	11,237	16,183	5,100
Tangible Book Value Per Share	779.07	934.66	353.83	1229.37	1770.47	663.00
Land	5,446	5,446	5,321	3,868	3,868	641.06
Buildings	4,028	4,061	4,192	4,323	4,455	4,586
Machinery	457.58	489.7	967.43	1,411	1,729	2,201
Construction In Progress	45	25.6	-	14.4	117.47	2,784